TCRT
TCRT clinical trials: Alaunos Therapeutics, Inc.
Every trial on ClinicalTrials.gov where Alaunos Therapeutics, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 44
- Trials linked
- 37
- As lead sponsor
- 7
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
TCRT on the catalyst calendar · TCRT registry changes
- Primary completion Sep 30, 2023ActualPhase 1/Phase 2NCT05194735Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid TumorsAlaunos Therapeutics · Gynecologic CancerTerminatedTCRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 20, 2025ActualNo phase registeredNCT05292859Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRsAlaunos Therapeutics · Gynecologic CancerCompletedTCRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 23, 2023ActualNo phase registeredNCT05124743HLA Typing & Tumor Neoantigen Identification for Phase I/II Study of Autologous TCR-T Cells in Subjects With Solid TumorsAlaunos Therapeutics · Ovarian CancerTerminatedTCRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 13, 2013ActualPhase 3NCT01168791Study of Palifosfamide-tris in Combination With Doxorubicin in Patients With Front-line Metastatic Soft Tissue SarcomaAlaunos Therapeutics · Soft Tissue SarcomaTerminatedTCRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 20, 2010ActualPhase 2NCT00718484A Study of Palifosfamide Tris Plus Doxorubicin Versus Doxorubicin in Unresectable or Metastatic Soft-tissue SarcomaAlaunos Therapeutics · Soft Tissue SarcomaTerminatedTCRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 16, 2008ActualPhase 1/Phase 2NCT00439686Study of ZIO-201 in Advanced SarcomaAlaunos Therapeutics · Advanced SarcomaCompletedTCRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2, 2014ActualPhase 3NCT01555710Study of Palifosfamide-tris in Combination With Carboplatin and Etoposide in Chemotherapy Naïve Patients With Extensive-Stage Small Cell...Alaunos Therapeutics · Extensive-Stage Small Cell Lung CancerTerminatedTCRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 3, 2012ActualPhase 1NCT01113970Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast CancerAlaunos Therapeutics · Metastatic Breast CancerTerminatedTCRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 9, 2008ActualPhase 2NCT00423306A Phase-II Trial of ZIO 101 in Advanced Hepatocellular CarcinomaAlaunos Therapeutics · Hepatocellular CarcinomaTerminatedTCRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 30, 2009ActualPhase 2NCT00421213Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow CancersAlaunos Therapeutics · Hematologic NeoplasmsTerminatedTCRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 29, 2009ActualPhase 1NCT00726687Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid TumorsAlaunos Therapeutics · Advanced Solid TumorsTerminatedTCRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 17, 2009ActualPhase 1NCT00591292Phase I Study in Advanced Solid TumorsAlaunos Therapeutics · Solid TumorsCompletedTCRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 1, 2012ActualPhase 1NCT01340547Effect on QTc, Pharmacokinetics, Safety, and Preliminary Efficacy of Single-agent Palifosfamide-tris in Subjects With Advanced Solid TumorsAlaunos Therapeutics · Advanced Solid TumorsCompletedTCRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 16, 2012ActualPhase 1NCT01242072Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With MalignanciesAlaunos Therapeutics · MalignancyCompletedTCRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2009Sponsor estimatePhase 1NCT00607711Study of Oral Palifosfamide Tris in Solid TumorsAlaunos Therapeutics · Advanced CancerWithdrawnTCRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 4, 2009ActualPhase 1NCT00592163Phase I Study of Oral ZIO-101-C in Advanced Solid Tumors and LymphomasAlaunos Therapeutics · Advanced Solid TumorsCompletedTCRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 10, 2010ActualPhase 1NCT00591422Phase I Study of Oral Darinaparsin (ZIO-101-C)in Advanced Solid Tumors and Non-Hodgkin's LymphomasAlaunos Therapeutics · Advanced CancerCompletedTCRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2008ActualPhase 1NCT00591383Phase I Study of Indibulin in Combination With Erlotinib in Advanced Solid TumorsAlaunos Therapeutics · Advanced Solid TumorsCompletedTCRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 21, 2007ActualPhase 2NCT00423644A Phase II Trial of ZIO-101 in Advanced Multiple Myeloma: Protocol SGL2001bAlaunos Therapeutics · Multiple MyelomaCompletedTCRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2014ActualPhase 1/Phase 2NCT01397708Safety Study of Adenovirus Vector Engineered to Express hIL-12 in Combination With Activator Ligand to Treat MelanomaAlaunos Therapeutics · MelanomaCompletedTCRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2, 2019ActualPhase 1NCT03679754Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102Alaunos Therapeutics · GlioblastomaCompletedTCRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 15, 2020ActualPhase 1NCT03636477A Study of Ad-RTS-hIL-12 With Veledimex in Combination With Nivolumab in Subjects With Glioblastoma; a Substudy to ATI001-102Alaunos Therapeutics · GlioblastomaCompletedTCRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 10, 2021ActualPhase 1/Phase 2NCT03330197A Study of Ad-RTS-hIL-12 + Veledimex in Pediatric Subjects With Brain Tumors Including DIPGAlaunos Therapeutics · Pediatric Brain TumorTerminatedTCRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 19, 2016ActualPhase 1/Phase 2NCT02423902A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Breast CancerAlaunos Therapeutics · Metastatic Breast CancerTerminatedTCRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 7, 2014ActualPhase 2NCT01703754Adenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer.Alaunos Therapeutics · Breast Cancer Nos Metastatic RecurrentTerminatedTCRTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 25 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerShowing the first 25 trials. There are 19 more in this window; the full list is part of TrialScanner.
Unlock with TrialScanner